David Rosenblum, MD
Pain Medicine · Brooklyn, NYNPI 1043309040
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.7%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Clarius Mobile Health Corp. at 40.6% of the total. Among pain medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 178 payments — averaging $591.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Clarius Mobile Health Corp.$43K
- SPR Therapeutics, Inc$23K
- Pfizer$16K
- Scilex Pharmaceuticals Inc.$10K
- Nalu Medical, Inc.$3K
- Pajunk Medical Systems, LP$3K
- plus $7K from 28 others
What the payments were for
- Consulting fees$29,13028%
- Speaking & faculty fees$56,51254%
- Travel & lodging$4,8685%
- Food & beverage$14,70314%
- Education$870%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Clarius Mobile Health Corp. | 10 | $42,768 |
| SPR Therapeutics, Inc | 46 | $23,400 |
| Pfizer | 2 | $15,500 |
| Scilex Pharmaceuticals Inc. | 9 | $10,236 |
| Nalu Medical, Inc. | 3 | $3,317 |
| Pajunk Medical Systems, LP | 1 | $2,862 |
| Relievant Medsystems, Inc. | 13 | $1,981 |
| Medtronic(2 entities) | 11 | $1,137 |
| Boston Scientific | 11 | $784 |
| Nevro Corp. | 13 | $695 |
| Si-bone, Inc. | 6 | $442 |
| Amgen(2 entities) | 8 | $353 |
| Abbott | 3 | $249 |
| GRT US Holding, Inc. | 2 | $219 |
| Painteq LLC | 2 | $131 |
| Collegium Pharmaceutical, Inc. | 6 | $128 |
| Esperion Therapeutics, Inc. | 1 | $125 |
| Pacira Pharmaceuticals Incorporated | 1 | $125 |
| Globus Medical | 1 | $116 |
| Mallinckrodt Hospital Products Inc. | 1 | $115 |
| Assertio Therapeutics, Inc. | 9 | $115 |
| Saluda Medical Americas, Inc. | 2 | $71 |
| Stimwave Technologies Incorporated | 2 | $67 |
| Vertex | 3 | $65 |
| Bioventus LLC | 2 | $60 |
| Curonix LLC | 1 | $45 |
| Biodelivery Sciences International, Inc. | 2 | $34 |
| Neuronetics, Inc. | 1 | $34 |
| MML US, Inc. | 1 | $30 |
| Johnson & Johnson | 1 | $28 |
| Almatica Pharma LLC | 1 | $25 |
| Cumberland Pharmaceuticals, Inc. | 1 | $16 |
| Novartis | 1 | $15 |
| Foundation Fusion Solutions, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRINT PNS System$22,424
- ZTLido$10,212
- Intracept$4,896
- Nalu Neurostimulation System$3,300
- E-CATH PLUS ACC. TSUI$2,862
- SPECTRA WAVEWRITER$415
- Omnia$378
- INTELLIS ADAPTIVESTIM$272
- AIMOVIG$250
- iFuse Implant$227
- Qutenza$219
- INTELLIS$158
- O-ARM$155
- MazorX - Renaissance$125
- NEXLIZET$125
- NEXLETOL$125
- EXPAREL$125
- WAVEWRITER ALPHA$121
- CD HORIZON$120
- TLIF$116
How this compares
$105,300 in reported general payments places this provider in the 95th percentile of 503 pain medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 14 | $16,586 |
| Xtampza ErOxycodone Myristate | 11 | $6,482 |
| Fentanyl | 42 | $4,439 |
| Pregabalin | 151 | $4,304 |
| ZtlidoLidocaine | 11 | $4,104 |
| Oxycodone Hcl | 123 | $3,550 |
| Lidocaine | 51 | $2,902 |
| Diclofenac Sodium | 14 | $2,454 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 117 | $2,201 |
| Gabapentin | 89 | $992 |
| Hydromorphone Hcl | 45 | $773 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $595 |
| Morphine Sulfate ErMorphine Sulfate | 22 | $588 |
| Tizanidine Hcl | 32 | $449 |
| Baclofen | 54 | $384 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Nucynta, Xtampza Er | $128 | $23,06825 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $10,236 | $4,10411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 503 pain medicine providers in New York.
Other pain medicine in Brooklyn
- Gary SchwartzBrooklyn$756K
- Jacob RauchwergerBrooklyn$41K
- Thomas del GuercioBrooklyn$22K
- Jason KreinerBrooklyn$18K
- Roman ShulkinBrooklyn$15K
- Amitabh GulatiNew York$614K
- William CaldwellStony Brook$530K
- Brian DurkinPort Jefferson$455K
- David SpinnerNew York$391K
- Grace FordeNew Hyde Park$355K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.